escalabio.com

Escala Therapeutics

Management & Board of Directors. ESCALA Therapeutics, Inc. A majority-owned subsidiary of Fortress Biotech, Inc., is a development stage company focused on the clinical development and commercialization of therapies for orphan disorders. We are currently developing N-acetyl-D-mannosamine (ManNAc) for the potential treatment of GNE myopathy and primary podocyte (glomerular) disorders in collaboration with NIH researchers. 2 Gansevoort Street, 9th Floor. New York, NY 10014.

http://www.escalabio.com/

OVERVIEW OF escalabio.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR ESCALABIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

May

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 10 reviews

5 star

7

4 star

0

3 star

3

2 star

0

1 star

0

Hey there! Start your review of escalabio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.8 seconds

FAVICON PREVIEW

16x16

CONTACTS AT ESCALABIO.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

10

SSL

EXTERNAL LINKS

2

SITE IP

69.168.8.230

LOAD TIME

1.844 sec

SCORE

6.2

PAGE TITLE

Escala Therapeutics | escalabio.com Reviews

<META> DESCRIPTION

Management & Board of Directors. ESCALA Therapeutics, Inc. A majority-owned subsidiary of Fortress Biotech, Inc., is a development stage company focused on the clinical development and commercialization of therapies for orphan disorders. We are currently developing N-acetyl-D-mannosamine (ManNAc) for the potential treatment of GNE myopathy and primary podocyte (glomerular) disorders in collaboration with NIH researchers. 2 Gansevoort Street, 9th Floor. New York, NY 10014.

<META> KEYWORDS

1 menu

2 about us

3 strategic advisory board

4 pipeline

5 clinical trials

6 publications

7 investors

8 corporate presentation

9 press releases

10 business development

CONTENT

Page content here

KEYWORDS ON PAGE

menu,about us,strategic advisory board,pipeline,clinical trials,publications,investors,corporate presentation,press releases,business development,info@escalabio com

SERVER

nginx

POWERED BY

PHP/5.6.23,PleskLin

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Escala Therapeutics | escalabio.com Reviews

https://escalabio.com

Management & Board of Directors. ESCALA Therapeutics, Inc. A majority-owned subsidiary of Fortress Biotech, Inc., is a development stage company focused on the clinical development and commercialization of therapies for orphan disorders. We are currently developing N-acetyl-D-mannosamine (ManNAc) for the potential treatment of GNE myopathy and primary podocyte (glomerular) disorders in collaboration with NIH researchers. 2 Gansevoort Street, 9th Floor. New York, NY 10014.

INTERNAL PAGES

escalabio.com

1

ABOUT US – Escala Therapeutics

http://www.escalabio.com/about-us

Management & Board of Directors. Management & Board of Directors. Escala Therapeutics (previously known as Altamira Biosciences, Inc.), is a development stage company focused on the clinical development and commercialization of N-acetyl-D-mannosamine (ManNAc) and other therapies for orphan/ultra-orphan, rare or neglected disorders. ManNAc is an intermediary in cellular sialic acid biosynthesis generated by the GNE protein known to be involved in GNE Myopathy. Preclinical data suggest that supplementa...

2

PIPELINE – Escala Therapeutics

http://www.escalabio.com/pipeline

Management & Board of Directors. ManNAc is currently under investigation in collaboration with NHGRI and NCATS researchers (NIH) in an open-label Phase 2 study for the treatment of GNE Myopathy. The FDA has provided orphan designation for ManNAc in GNE Myopathy. In addition, a Phase 1 study to investigate ManNAc safety and tolerability in patients with a range of glomerular diseases (primary podocyte diseases) associated with hyposialylation is currently recruiting.

3

INVESTORS – Escala Therapeutics

http://www.escalabio.com/investors

Management & Board of Directors. Escala Therapeutics, Inc., a majority-owned subsidiary of Fortress Biotech, Inc., is a development stage company focused on the clinical development and commercialization of N-acetyl-D-mannosamine (ManNAc) in collaboration with NIH investigators. Escala Therapeutics, Inc. is also seeking new academic and industry partnerships to develop other therapies for orphan/ultra-orphan, rare or neglected disorders. Escala Therapeutics, Inc. New York, NY 10014. No 1 London Bridge.

4

Fortress Biotech Subsidiary, Escala Therapeutics, Acquires NIH License and CRADAs Relating to the Development of N-acetyl-D-mannosamine (ManNAc) for Rare Genetic Disorders – Escala Therapeutics

http://www.escalabio.com/2015/07/17/press-release

Management & Board of Directors. July 17, 2015. Fortress Biotech Subsidiary, Escala Therapeutics, Acquires NIH License and CRADAs Relating to the Development of N-acetyl-D-mannosamine (ManNAc) for Rare Genetic Disorders. ManNAc to be Studied as Potential Treatment of Hereditary Inclusion Body Myopathy (HIBM) and Various Nephropathies Associated with Hyposialylation. New York, NY July 17, 2015. Lucy Lu, MD, Executive Vice President and Chief Financial Officer. Fortress Biotech, Inc.

5

Strategic Advisory Board – Escala Therapeutics

http://www.escalabio.com/about-us/strategic-advisory-board

Management & Board of Directors. Management & Board of Directors. Marlene Haffner, M.D. Dr Haffner is an internist and hematologist who graduated from the George Washington University School of Medicine and did further training at the Columbia University School of Medicine and the Albert Einstein College of Medicine, in New York City. Marlene received her Masters of Public Health from the Johns Hopkins Bloomberg School of Public Health in Baltimore. Philippe Monteyne, MD, PhD. Trained as a Medical Doctor...

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

LINKS TO THIS WEBSITE

fortressbiotech.com

Fortress Biotech - Specializing in Acquiring, Developing and Commercializing Novel Pharmaceutical and Biotechnology Products

http://www.fortressbiotech.com//index.cfm

Mustang Bio, Inc. October 28, 2016:. Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in. October 17, 2016:. Journey Medical Corporation Launches Targadox™ Oral Immediate-Release Tablet for Treatment of Severe Acne. October 3, 2016:. Checkpoint Therapeutics Initiates Phase 1/2 Study of CK-101 – A Novel Third-Generation EGFR Inhibitor. September 23, 2016:. Checkpoint Therapeutics to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference. September 12, 2016:.

fortressbiotech.com

Fortress Biotech - Specializing in Acquiring, Developing and Commercializing Novel Pharmaceutical and Biotechnology Products

http://www.fortressbiotech.com/portfolio-companies/altamira-bio.cfm

Mustang Bio, Inc. October 28, 2016:. Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in. October 17, 2016:. Journey Medical Corporation Launches Targadox™ Oral Immediate-Release Tablet for Treatment of Severe Acne. October 3, 2016:. Checkpoint Therapeutics Initiates Phase 1/2 Study of CK-101 – A Novel Third-Generation EGFR Inhibitor. September 23, 2016:. Checkpoint Therapeutics to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference. September 12, 2016:.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

escalabel.societeg.com

IIS7

escalaberazza.com

Escala Berazza

escalabilidad.com

Account Suspended

This Account has been suspended. Contact your hosting provider for more information.

escalabilidad.org

Home

Está aquí: .

escalabilidade.com.br

Serviços de Cloud Gerenciado e Hospedagem de Sites | CentralServer

Acessar o Portal do HotBackup. Acessar o Email Marketing Pro. Atendimento: 0800 701 1993. 55 (11) 4063.6549. 55 (41) 2141.1800. Serviços Do básico ao completo. Data Center Virtual (DCV). Cloud Infraestrutura com Plesk e cPanel. Soluções Sob medida para você. Atendimento Precisa de ajuda? Parceria Aumente seus ganhos. Empresa Conheça nossa estrutura. Fale com a Diretoria. PESQUISA de domínioS →. Mude para a CentralServer. Veja como é fácil transferir seu domínio para a CentralServer em apenas 4 passos.

escalabio.com

Escala Therapeutics

Management & Board of Directors. ESCALA Therapeutics, Inc. A majority-owned subsidiary of Fortress Biotech, Inc., is a development stage company focused on the clinical development and commercialization of therapies for orphan disorders. We are currently developing N-acetyl-D-mannosamine (ManNAc) for the potential treatment of GNE myopathy and primary podocyte (glomerular) disorders in collaboration with NIH researchers. 2 Gansevoort Street, 9th Floor. New York, NY 10014.

escalabiomedica.com

Nosotros

ESCALA BIOMÉDICA S.C. Asesoría en ingeniería clínica, procesos de salud relacionados con infraestructura y tecnología medica. El éxito está basado en la confianza generada en nuestros socios de negocio. Nuestra consultoría se fundamenta en el análisis y solución de problemas con respecto al uso y actualización de la tecnología, sistemas de información e infraestructura, dentro del sector salud. Asesoría en ingeniería clínica, procesos de salud relacionados con infraestructura y tecnología medica. Bienven...

escalabitano.com

Escalabitano

Área restrita para Distribuidores. O Azeite Escalabitano é um azeite ligeiramente frutado de azeitonas maduras, com notas suaves de maçã e tomate verde, pouco persistente na boca, ideal para as suas refeições. Qualidade do Azeite ae. D Fernando 2000-243 Achete. 351) 969 451 390.

escalable.com

escalable.com - Escalable Resources and Information.

This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

escalable.net

Non-Existent Domain

Your browser does not support iframes, please click here.

escalablocos.com.br

home

Tel: 67-3522 0979 / 3521 9756. Subscribe to this RSS feed. Thursday, 20 June 2013 04:50. Trata-se do mais moderno e avançado sistema de fabricação de pré-moldados, ou seja, tecnologia de ponta para atender e suprir as necessidades dos nossos cliente. A Empresa (VER FOTOS). Fabricamos blocos de concreto ( estrutural e vedação), canaleta (estrutural e vedação), pavimentos e pisos intertravados, todos apresentando medidas que atendem às especificações da ABNT (Associação Brasileira de Normas Técnicas).